Skip to main content
OpenTrials
Completed

NCT Number: NCT06478901

Precision of AI-Based Cardiac Ultrasound for LVEF in the Elderly

Heart failure (HF) is common in older adults, especially those over 65. It is a leading cause of hospitalization and has high mortality rates. Diagnosing HF in elderly patients can be challenging due to atypical symptoms and multiple other health issues. Echocardiography, an ultrasound of the heart, is crucial for accurate diagnosis and treatment planning.

One problem in geriatric care is the difficulty of accessing echocardiography due to high demand and limited specialized doctors. Recent advancements show that AI-assisted portable ultrasound devices can reliably measure heart function, producing results comparable to traditional methods.

This study aims to evaluate the accuracy and relevance of AI-assisted echocardiography (AutoEF-AI) in elderly patients. It also assesses whether geriatricians, even without specialized training, can capture quality images for AI analysis.

In simple terms, this study investigates if portable ultrasound devices with AI can provide precise heart function diagnostics, making it easier for older adults with heart failure to get the care they need, even without specialists.

Completed

Looking for future studies?

Notify Me

Key information

Age range

75 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Broca

Paris, 75013, France

About this study

Heart failure (HF) is a major chronic illness, particularly common in older adults. With advances in healthcare and an aging population, HF is increasingly affecting people over 65 years old. In fact, 80% of HF patients are over 65. HF is associated with high mortality rates and is the leading cause of hospitalization after age 80, and even after age 65 in some countries like France.

In older adults, HF symptoms are often atypical due to multiple other health conditions, increased frailty, and associated geriatric syndromes, making diagnosis difficult. In this context, echocardiography (an ultrasound of the heart) is essential for accurately diagnosing HF.

Evaluating the left ventricular ejection fraction (LVEF) through echocardiography is a fundamental step in diagnosing HF and deciding on treatment strategies. This evaluation helps refine the HF diagnosis, propose appropriate treatments, and monitor changes in heart function over time.

One major challenge in geriatric units and nursing homes (EHPADs) is the difficulty in accessing echocardiography due to growing demand and a limited number of specialized doctors.

Recent studies have shown that automated LVEF measurements assisted by artificial intelligence (AI) using portable ultrasound devices are reliable and produce results comparable to traditional methods. This AI-assisted automatic LVEF calculation (AutoEF-AI) could be a major advantage in geriatric departments, providing a credible alternative to conventional echocardiography for evaluating LVEF in HF patients.

The main goal of this study was to evaluate the relevance and accuracy of AutoEF-AI echocardiography in elderly patients. The secondary goal was to assess whether geriatricians without specialized training in echocardiography could capture images of sufficient quality to be analyzed by automatic LVEF algorithms with acceptable accuracy.

In simple terms, this study aims to determine if using portable ultrasound devices, assisted by artificial intelligence, can provide diagnostics as precise as traditional methods. This could make evaluating heart function more accessible and effective for older adults with heart failure, even when specialists are not available.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • At least 75 years and a clinical presentation of acute heart failure consistent with the criteria of the European Society of Cardiology guidelines

Exclusion criteria

  • unstable patient

Treatment and study plan

Echocardiography

Device

Echocardiography assited by Artificial intelligence

Primary outcomes

  1. evaluate the relevance and accuracy of echocardiography assisted by Artificial intelligence in elderly patients

    Time frame: From enrollment to the end 48 hours

    The correlation between LVEF measurements from standard echocardiography and AutoEF-AI echocardiography was assessed using the intraclass correlation coefficient (ICC) and Bland-Altman analysis. Weighted Kappa coefficient was calculated to determine agreement between measurements in classifying patients into different categories based on LVEF

Sponsors and collaborators

Lead sponsor

Hôpital Broca APHP

Other

Registry information

Official study title

Precision and RElevance of CardIac ultraSound Using Artificial Intelligence for Left Ventricle Ejection Fraction Assessment in the Elderly. ( PRECISE AI)

Acronym: PRECISE AI

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Jun 27, 2024
Registry last updated
Jun 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.